Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Capicua transcriptional repressor pseudogene 21 (CICP21)
- Target
- CICP21
- Molecular classification
- Pseudogene, Non-coding RNA
01
Overview
Capicua transcriptional repressor pseudogene 21 (CICP21) is a genomic sequence classified as a pseudogene, meaning it has significant sequence similarity to the functional capicua transcriptional repressor (CIC) gene but is non-functional due to acquired mutations or regulatory changes. Pseudogenes such as CICP21 generally do not encode functional proteins but may sometimes produce RNA transcripts that regulate the expression of their parent genes through competitive endogenous RNA mechanisms or the generation of regulatory small RNAs. There is currently no evidence supporting CICP21 as a therapeutic target, druggable receptor, or direct disease biomarker.
- Other names
- Capicua homolog pseudogeneCICP21Capicua transcriptional repressor pseudogene 21
02
Mechanism of action
None applicable. No drugs target CICP21; pseudogene RNAs can potentially influence regulatory networks but CICP21-specific mechanisms have not been described
03
Biological functions
None directly documented for CICP21; pseudogene transcripts can sometimes regulate their parent genes via noncoding RNA mechanisms, such as acting as competitive endogenous RNAs (ceRNAs), antisense transcripts, precursors for small interfering RNAs (siRNAs), or piwi-interacting RNAs (piRNAs)
04
Disease associations
No established direct role in diseasePseudogenes in general may have indirect effects in cancer or gene regulation if transcribed
05
Safety considerations
None known or anticipated, since CICP21 is not targeted by therapies nor proposed as a biomarker
Beyond the preview
Go deeper on Capicua transcriptional repressor pseudogene 21 (CICP21).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Capicua transcriptional repressor pseudogene 21 (CICP21).